Global Generic Drugs Market Size, Share and Forecast 2016-2026 | TechSci Research

GLOBAL GENERIC DRUGS MARKET

FORECAST & OPPORTUNITIES

2016 – 2026

MARKET INTELLIGENCE . CONSULTING

www.techsciresearch.com

2

Scope of ReportProduct of Interest (POI): Generic Drugs

Review Period

2016 – 2019

Base Year

2020

Estimated Year

2021

Forecast Period

2022 – 2026

Year Range

A generic drug is a pharmaceutical drug that contains the samechemical substance as a drug that was originally protected by chemicalpatents. Generic drugs are allowed for sale after the patents on theoriginal drugs expire.

Market Segmentation

TYPE

• Small Molecule Generics

• Biosimilars

DRUG DELIVERY

• Oral

• Topical

• Parenteral

• Others

REGION

• Europe

• North America

• South America

• Middle East & Africa

• Asia Pacific

APPLICATION

• Cardiovascular Diseases.

• Diabetes

• Neurology

• Oncology

• Anti-Inflammatory Diseases

• Others

FORM

• Tablet

• Capsule

• Injection

• Others

SOURCE

• In House

• Contract Manufacturing Organizations

DISTRIBUTION CHANNEL

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

• Others

3

Table of Contents

S. No. Contents Page No.

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Generic Drugs Market

4. Executive Summary

5. Voice of Customer

5.1. Brand Awareness

5.2. Factors driving Global Generic Drugs Market

5.3. Factors Influencing Drug Purchase Decision

6. Global Generic Drugs Market Outlook, 2016-2026F

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Type (Small Molecule Generics vs Biosimilars)

6.2.2.By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others)

6.2.3. By Drug Delivery (Oral, Topical, Parenteral, Others)

6.2.4. By Form (Tablet, Capsule, Injection, Others)

6.2.5. By Source (In House vs Contract Manufacturing Organizations)

6.2.6. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others

6.2.7. By Region

6.2.8. By Company (2020)

6.3. Product Market Map

4

Table of Contents


7. Asia-Pacific Generic Drugs Market Outlook, 2016-2026F


7.1.1. By Value


7.2.1. By Type

7.2.2. By Application

7.2.3. By Drug Delivery

7.2.4. By Form

7.2.5. By Source

7.2.6. By Distribution Channel

7.2.7. By Country (China; India; Japan; South Korea; Australia)

7.3. Asia-Pacific: Country Analysis

7.3.1. China Generic Drugs Market Outlook, 2016-2026F

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Type

7.3.1.2.2. By Application

7.3.1.2.3. By Drug Delivery

7.3.1.2.4. By Form

7.3.1.2.5. By Source

7.3.1.2.6. By Distribution Channel

5

Table of Contents


7.3.2. India Generic Drugs Market Outlook, 2016-2026F


7.3.2.1.1. By Value


7.3.2.2.1. By Type



7.3.2.2.4 By Form



7.3.3. Australia Generic Drugs Market Outlook, 2016-2026F


7.3.3.1.1. By Value


7.3.3.2.1. By Type



7.3.3.2.4. By Form



6

Table of Contents


7.3.4. Japan Generic Drugs Market Outlook, 2016-2026F


7.3.4.1.1. By Value


7.3.4.2.1. By Type



7.3.4.2.4 By Form



7.3.5. South Korea Generic Drugs Market Outlook, 2016-2026F


7.3.5.1.1. By Value


7.3.5.2.1. By Type



7.3.5.2.4. By Form



7

Table of Contents


8. Europe Generic Drugs Market Outlook, 2016-2026F


8.1.1. By Value


8.2.1. By Type



8.2.4. By Form

8.2.5. By Source


8.2.7. By Country (France, Germany, United Kingdom, Italy, Spain)

8.3. Europe: Country Analysis

8.3.1. France Generic Drugs Market Outlook, 2016-2026F


8.3.1.1.1. By Value


8.3.1.2.1. By Type



8.3.1.2.4. By Form



8

Table of Contents


8.3.2. Germany Generic Drugs Market Outlook, 2016-2026F


8.3.2.1.1. By Value


8.3.2.2.1. By Type



8.3.2.2.4 By Form



8.3.3. United Kingdom Generic Drugs Market Outlook, 2016-2026F


8.3.3.1.1. By Value


8.3.3.2.1. By Type



8.3.3.2.4. By Form



9

Table of Contents


8.3.4. Italy Generic Drugs Market Outlook, 2016-2026F


8.3.4.1.1. By Value


8.3.4.2.1. By Type



8.3.4.2.4 By Form



8.3.5. Spain Generic Drugs Market Outlook, 2016-2026F


8.3.5.1.1. By Value


8.3.5.2.1. By Type



8.3.5.2.4. By Form



10

Table of Contents


9. North America Generic Drugs Market Outlook, 2016-2026F


9.1.1. By Value


9.2.1. By Type



9.2.4. By Form

9.2.5. By Source


9.2.7. By Country (United States, Mexico, Canada)

9.3. North America: Country Analysis

9.3.1. United States Generic Drugs Market Outlook, 2016-2026F


9.3.1.1.1. By Value


9.3.1.2.1. By Type



9.3.1.2.4. By Form

11

Table of Contents




9.3.2. Mexico Generic Drugs Market Outlook, 2016-2026F


9.3.2.1.1. By Value


9.3.2.2.1. By Type



9.3.2.2.4 By Form



9.3.3. Canada Generic Drugs Market Outlook, 2016-2026F


9.3.3.1.1. By Value


9.3.3.2.1. By Type



9.3.3.2.4. By Form



12

Table of Contents


10. South America Generic Drugs Market Outlook, 2016-2026F


10.1.1. By Value


10.2.1. By Type



10.2.4. By Form

10.2.5. By Source


10.2.7. By Country (Brazil, Argentina, Colombia)

10.3. South America: Country Analysis

10.3.1. Brazil Generic Drugs Market Outlook, 2016-2026F


10.3.1.1.1. By Value


10.3.1.2.1. By Type



10.3.1.2.4. By Form

13

Table of Contents


10.3.1.2.5. By Source


10.3.2. Argentina Generic Drugs Market Outlook, 2016-2026F


10.3.2.1.1. By Value


10.3.2.2.1. By Type



10.3.2.2.4 By Form

10.3.2.2.5. By Source


10.3.3. Colombia Generic Drugs Market Outlook, 2016-2026F


10.3.3.1.1. By Value


10.3.3.2.1. By Type



10.3.3.2.4. By Form

10.3.3.2.5. By Source


14

Table of Contents


11. Middle East and Africa Generic Drugs Market Outlook, 2016-2026F


11.1.1. By Value


11.2.1. By Type



11.2.4. By Form

11.2.5. By Source


11.2.7. By Country (South Africa, Saudi Arabia, UAE)

11.3. Middle East and Africa: Country Analysis

11.3.1. South Africa Generic Drugs Market Outlook, 2016-2026F


11.3.1.1.1. By Value


11.3.1.2.1. By Type



11.3.1.2.4. By Form

15

Table of Contents


11.3.1.2.5. By Source


11.3.2. Saudi Arabia Generic Drugs Market Outlook, 2016-2026F


11.3.2.1.1. By Value


11.3.2.2.1. By Type



11.3.2.2.4 By Form

11.3.2.2.5. By Source


11.3.3. UAE Generic Drugs Market Outlook, 2016-2026F


11.3.3.1.1. By Value


11.3.3.2.1. By Type



11.3.3.2.4. By Form

11.3.3.2.5. By Source


16

Table of Contents


12. Market Dynamics

12.1. Drivers

12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

14.1. Competition Outlook

14.2. Company Profiles

14.2.1. Teva Pharmaceutical Industries Ltd.

14.2.2. Lupin Limited

14.2.3. Mylan NV

14.2.4. Sandoz International GmbH (Novartis AG)

14.2.5. Pfizer Inc.

14.2.6. Sun Pharmaceutical Industries Limited

14.2.7. Endo Pharmaceuticals Inc.

17.2.8. Aurobindo Pharma Limited

14.2.9. Dr Reddy’s Laboratories Ltd.

14.2.10. Fresenius Kabi AG

14.2.11. Aspen Pharmacare Holdings Limited

14.2.12. Sanofi SA

17

Table of Contents


14.2.13. Cipla Ltd.

14.2.14. Novo Nordisk A/S

14.2.15. Abbott Laboratories Inc.

15. Strategic Recommendations

16. About Us and Disclaimer

RESEARCH METHODOLOGY

19

Research Methodology

✓ Identifying Key Opinion

Leaders

✓ Questionnaire Design

✓ In-depth Interviews

Data Collection

Developing List of Respondents

Formulating Questionnaire

Market Profiling

Data Validation

Data Analysis

In-depth secondary research was conducted to

determine top players in the global generic drugs

market, overall market size and segmental market size.

In order to conduct industry experts’

interviews, TechSci formulated a detailed

discussion guide.

List of industry players and industry

specialists was developed.

TechSci conducted interviews with

industry experts and industry players for data collection and

verification.

Data obtained as a result of primary and secondary research was

validated through rigorous

triangulation.

The data was scrutinized using MS-Excel, statistical

tools and internal proprietary database to obtain qualitative and

quantitative insights about the global generic drugs

market.

Data Collection

Data Filter& Analysis

Research &Intelligence

ActionableInsights

BusinessSolution

Primary Research Desk Research Company Analysis

✓ Recent Developments

✓ Market Changing

Aspects/Dynamics

✓ Government Policies

✓ Conclusion

✓ Market Participants

✓ Key Strengths

✓ LinkedIn✓ TechSci Internal

Database

✓ Factiva✓ Hoovers

Paid Sources

✓ Company Websites✓ Company Annual

Reports✓ White Paper Study✓ Financial Reports✓ Investor

Presentations✓ Regulatory Body✓ Associations, etc.

Secondary Research

Primary Research

20


Baseline Methodology

Our dedicated team of industry experts has monitored and analyzed various aspects of the global generic drugs market. The team has

analyzed the outlook of various segments of this market, while considering the major influencing factors such as increasing awareness about

generic drugs. The study includes market forecasting, which would enable our clients to take better decisions while planning their strategy to

achieve sustainability in the global generic drugs market.

Methodology Followed for Calculation of Market Size:

• Market Size by Value & Volume : Market size, in terms of value, for the year 2020 was calculated based on information collected through

exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as generic drugs manufacturers,

channel partners, market influencers & end users, industry experts, and other industry participants.

• The team interviewed more than 15 – 20 generic drugs manufacturers, 100 – 120 end users, and 15 – 20 industry experts and other value

chain stakeholders in the global generic drugs market to obtain the overall market size from 2016 to 2020, which was validated by the Delphi

technique. Taking standard deviation into consideration, the market size was averaged out, to arrive at the market size data during 2016-

2020.

21


• Respondents were asked about the current and future market growth rates, market shares by type, by application, by drug delivery, by

form, by source, by distribution channel, by company and by each region. Removing the outlier responses, the geometric mean of growth

estimates and provider wise revenue shares generated across various segments were considered, to arrive at the final revenue shares.

Revenue shares generated across various type were further triangulated from other stakeholders.

Methodology Followed for Calculation of Market Shares:

• Market shares by type, by application, by drug delivery, by form, by source, by distribution channel, by company and by each region were

calculated based on the responses received through primary surveys with industry experts, in which the respondents were asked about the

market shares or revenue generated from various types of generic drugs. The final shares were calculated by taking the geometric mean of

the responses gathered from key opinion leaders after eliminating the outliers.

Methodology Followed for Forecasting:

• TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in

SPSS/Tableau Software.

• Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast global

generic drugs market, TechSci Research used various forecast techniques such as:

✓ Moving Average

✓ Time Series Analysis

✓ Regression Analysis

✓ Econometric and Judgmental Analysis

22


TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research

also used the impact analysis during short, medium and long term period to estimate the demand and to reach accurate market numbers. It

should be noted that the figures compiled are only for the organized market including market share data. The currency used in the report is the

United States Dollar (USD), with the market size indicated in USD million.

Partial List of Companies Interviewed Key Secondary Sources

▪ Teva Pharmaceutical Industries Ltd.▪ Mylan NV▪ Sandoz International GmbH (Novartis AG)▪ Lupin Limited▪ Pfizer Inc.▪ Sun Pharmaceutical Industries Limited▪ Endo Pharmaceuticals Inc. ▪ Aurobindo Pharma Limited▪ Dr Reddy’s Laboratories Ltd.▪ Fresenius Kabi AG▪ Aspen Pharmacare Holdings Limited▪ Sanofi SA▪ Cipla Ltd.▪ Novo Nordisk A/S▪ Abbott Laboratories Inc.

▪ World Bank

▪ International Monetary Fund (IMF)

▪ TechSci Research Proprietary Database & Knowledge

Repository

▪ Company Annual Reports

▪ Industry Magazines

▪ Industry Reports

▪ News Dailies

▪ Credible Paid Databases

23

Industry Brief

According to TechSci Research report, “Global Generic Drugs Market, By Type (Small Molecule Generics vs Biosimilars), By Application

(Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others), By Drug Delivery (Oral, Topical, Parenteral, Others),

By Form (Tablet, Capsule, Injection, Others), By Source (In house vs Contract Manufacturing Organizations), By Distribution Channel (Hospital

Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Region, By Company, Competition, Forecast & Opportunities, 2026”, Global generic

drugs market was valued at USD371.04 billion in 2020 and is anticipated to reach USD564.43 billion until 2026 by witnessing a growing CAGR of

7.08% during the forecast period. Rising healthcare expenditure is one of the major factors accounting for the growth of global generic drugs market.

Moreover, initiatives taken by the governments of various countries to promote the use of generic drugs is expected to bode well for the growth of

global generic drugs market through the forecast period. In addition to this, surging demand for newer versions of generic drugs is positively influencing

the growth of global generic drugs market in the years to come. Along with this, upsurge in the number of generic drug approvals across the globe will

positively contribute to the market growth in the next 5 years. However, there are certain factors that might act as major impediments to the growth of

global generic drugs market during the forecast period such as stringent governmental regulations and adverse effects associated with drugs.

Global generic drugs market can be segmented based on type, application, drug delivery, form, source, distribution channel, company, and region.

Considering the distribution channel, the market is fragmented into hospital pharmacies, retail pharmacies, online pharmacies, others. The retail

pharmacies segment dominated the global generic drugs market with the market share of 46% until 2020 and is further anticipated to maintain its

dominance during the forecast period as well. This is because most of the generic drugs are available over the counter. Based on form, the market is

segregated into tablet, capsule, injection, others. The tablet segment dominated the market by holding major share in the market on account of certain

benefits it offers such as cost effectiveness and longer shelf life of tablets. Based on source, the market can be categorized into in-house v/s contract

manufacturing organizations. The in-house segment dominated the market until 2020 as most of the leading companies focused on in house

production. Contract manufacturing organizations segment is expected to witness high CAGR in the forecast period on account of certain operational

advantages it offers, especially when the demand for a specific product is high in the market and contract manufacturer provides additional production

capacity to satisfy the customer.

Teva Pharmaceutical Industries Ltd, Mylan NV, Sandoz International GmbH (Novartis AG), Lupin Limited, Pfizer Inc., Sun Pharmaceutical Industries

Limited, Endo Pharmaceuticals Inc., Aurobindo Pharma Limited, Dr Reddy’s Laboratories Ltd., Fresenius Kabi AG, Aspen Pharmacare Holdings

Limited, Sanofi S.A., Cipla Ltd., Novo Nordisk A/S, Abbott Laboratories Inc., are the leading players operating in global generic drugs market. The

leading players are adopting several growth strategies to enhance the market scenario of generic drugs. Other competitive strategies include product

launches; mergers & acquisitions; agreements, partnerships, and collaborations; and expansions to diverse their product portfolio in order to strengthen

their market position.

North America is forecasted to dominate the global generic drugs market in the next 5 years on account of increasing prevalence of diabetes and

cardiovascular diseases in the region. Furthermore, growth in geriatric population is also contributing to the growing trend. Asia-Pacific region is

forecast to register highest growing CAGR over the years to come, which can be attributed to the fact that India manufactures around 60% of total

generic drugs across the globe. Additionally, China is the main supplier of Active Pharmaceutical Ingredients to India for generic drug manufacturing,

which is forecasted to drive the regional growth in upcoming years.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research

based global management consulting firm.

24

Sample Data - Snapshot

Global Generic Drugs Market Size, By Value (USD Million), 2016–2026F

XX% YY%

5.00 6.00 7.00 8.00 9.00 10.00 11.00 12.00 13.00 14.00 15.00

2016 2020 2021E 2026F

By Value (USD Million)CAGR By Value CAGR By Value

55%55%55%55%55%55%55%55%55%55%55%

45%45%45%45%45%45%45%45%45%45%45%

2016

2017

2018

2019

2020

2021E

2022F

2023F

2024F

2025F

2026F

Small Molecule Generics Biosimilars

Asia-Pacific Generic Drugs Market Share, By Type, By Value, 2016–2026F

20%20%20%20%20%20%20%20%20%20%20%

30%30%30%30%30%30%30%30%30%30%30%

20%20%20%20%20%20%20%20%20%20%20%

10%10%10%10%10%10%10%10%10%10%10%

10%10%10%10%10%10%10%10%10%10%10%

10%10%10%10%10%10%10%10%10%10%10%

2016

2017

2018

2019

2020

2021E

2022F

2023F

2024F

2025F

2026F

Cardiovascular Diseases Diabetes Neurology Oncology Anti-Inflammatory Diseases Others

India Generic Drugs Market Share, By Application, By Value, 2016–2026F

25

Report Ordering

Report Name: GLOBAL GENERIC DRUGS MARKET

FORECAST & OPPORTUNITIES2016 – 2026

To View Sample OR Purchase Report

License Type Price

Single User License $4450

Multi-User License $5450

Custom Research License $9450

https://www.techsciresearch.com/report/generic-drugs-market/7332.html

About Us & Disclaimer

TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in

number of areas to organizations. The company uses innovative business models that focus on improving productivity, while ensuring creation of high-quality reports. The

proprietary forecasting models use various analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’

model of a country, regional and global industry prospects. Combined with the detailed analysis of company activity and industry trends, the result is a uniquely rich

evaluation of the opportunities available in the market.

Related Reports

• Global Biochip Market By Technology (Microarray v/s Microfluidics), By Type (DNA Chips, Lab-On-a-Chips, Protein Chips, Others), By

Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Others), By End User (Biotechnology &

Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institutes, Others), By Region, Competition Forecast &

Opportunities, 2026.

• Global Clinical Trials Market By Type (Pharmaceutical Trials Vs Medical Device Trials), By Phase (Phase I, Phase II, Phase III, Phase IV), By

Study Design (Interventional, Observational, Expanded Access), By Indication (Autoimmune/Inflammation, Oncology, CNS, Diabetes,

Cardiovascular, Others), By End User (Clinical Research Organizations, Pharmaceutical and Biotechnological Companies, Clinical Testing

Laboratories, Others), By Company, By Region, Forecast & Opportunities, 2026

The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely,accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it considersreliable and firsthand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors oromissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of thisreport. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative marketsize and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior approval of TechSci Research.

TechSci Research – North America708 Third Avenue, Manhattan,

New York, United StatesTel: +1- 646- 360- 1656

Email: [email protected] www.techsciresearch.com

Disclaimer

TechSci Research – Europe54, Old brook, Bretton,

Peterborough, United Kingdom


TechSci Research – Asia-PacificB – 44, Sector – 57, Noida, National Capital

Region, U.P. - IndiaTel: +91-120-4523900


Health & Medicine

Global Generic Drugs Market Size, Share and Forecast 2016-2026 | TechSci Research